|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3CLPRO (1) | 3D printing (1) |
| 3D bio-ink printing (1) | 3D QSAR (1) | 3D-QSAR (1) |
| 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
| 6 (1) | 6-beta naltrexol (1) | 6-Mercaptopurine (1) |
| 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) | 7 (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) |
| A. nilotica (1) | ABC analysis (5) | ABC-VED matrix (4) |
| ABC-VEN analysis (1) | Abdominal pain (1) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| Abstinence (1) | ABTS (1) | Abuse (1) |
| Acacetin (1) | Academic Stressors scale (1) | Acalypha indica (1) |
| Acarbose (1) | Accuracy. (1) | Accurate (1) |
| ACE (2) | ACE inhibitor (1) | ACE2 receptor (1) |
| Aceclofenac (1) | ACEIs (1) | Acetaminophen (2) |
| Acetazolamide (1) | Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) |
| Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) | Acetylation rate (1) |
| Acetylcholinesterase (5) | Acetylcholinesterase inhibitors (1) | ACF (1) |
| Achillea millefolium L. (2) | Acid hydrolysis (1) | Acid violet 43 (1) |
| Acid-resistant capsules (1) | Acne (2) | Acne vulgaris (1) |
| Aconitine (1) | Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) |
| Act score (1) | ACTD (1) | Actinomycetes (1) |
| Activator procaspase-3 (1) | Active metabolites (2) | active pharmaceutical ingredient (1) |
| Active site (1) | Activities of daily living (ADL) scale (1) | Activity domain (1) |
| Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
| Acute Inflammation (1) | Acute inß ammation (1) | Acute Kidney Damage (1) |
| Acute poisoning (1) | Acute renal failure (1) | Acute Severe Pancreatitis (1) |
| Acute Side Effects (1) | Acute ST segment elevation myocardial infarction (1) | Acute toxicity (2) |
| acyclovir (2) | Adapalene (1) | ADE (1) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (2) |
| ADME properties. (1) | Adnexal masses (1) | ADR (2) |
| ADR (Adverse Drug Reaction) (3) | ADR management (1) | ADR monitoring centre (AMC). (1) |
| ADR reporting (1) | ADR(Adverse Drug Reaction) (1) | ADRs (2) |
| Adsorbent (1) | Adults. (1) | Adverse drug event (1) |
| adverse drug events (1) | Adverse drug reaction (16) | Adverse Drug Reaction (ADR) (1) |
| Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse Drug Reaction Reporting Systems (2) | Adverse drug reaction. (1) |
| Adverse Drug Reactions (10) | Adverse drug reactions (ADRs) (1) | Adverse effects (1) |
| Adverse event following immunization (AEFI) (1) | Adverse events (2) | Adverse reaction (1) |
| Aedes aegypti (2) | Aedes aegypti L (1) | Aedes albopictus (1) |
| Aerobic exercise (1) | Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) |
| Age (2) | Aged People (1) | Ageratum conyzoides L (1) |
| Agrobacterium (1) | air pollution (1) | Airjet (1) |
| Albendazole (1) | Albino mice (1) | Albino wistar rats (1) |
| Albumin Denaturation (1) | Alcohol (4) | Alcohol withdrawl seizure (1) |
| alcoholic extract (1) | ALDEN (1) | Aldose reductase inhibitors (1) |
| Alkaloids (1) | allantoin (1) | Allergic reactions (1) |
| Allergic rhinitis (1) | Allergy (4) | Allium sativum (1) |
| Alloxan (1) | Alloxan monohydrate (1) | Alocasia indica Schott (1) |
| Aloe vera (1) | Alpha mangostin (1) | Alpha-adrenoceptor (1) |
| alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
| Alteration of drug cost (1) | Altered Mental Status (AMS) (1) | Alternative medications (1) |
| alternative therapy (1) | Altmetric (1) | Aluminium chloride (2) |
| Alzheimer's disease (1) | Alzheimers disease (1) | Alzheimer’s disease (3) |
| Amaranthus spinosus Linn (1) | Amber (1) | Ambroxol hydrochloride (1) |
| Ambulatorial Surgery Procedures (1) | Ambulatory patients. (1) | Amides (1) |
| Amikacin Sulfate (1) | Amino acids (1) | amino benzylated Mannich bases (1) |
| Amisulpride (1) | amivudine (1) | Amlodipine (2) |
| Amlodipine besylate (2) | Ammonium salts (1) | Amoora cucullata. (1) |
| amoxicillin (1) | Amoxicillin - clavulanic acid (1) | Amoxicillin sodium (1) |
| Amphotericin B (1) | Amrād Wabā’ī (1) | Anabolic steroids (1) |
| Anabolic. (1) | Anaemia (2) | Analgesia (1) |
| analgesic (10) | Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) |
| Analgesics (1) | Analysis in capsules (1) | Analysis of variance (1) |
| Analytical methods (1) | Anaphylactic shock (1) | Anaphylaxis. (1) |
| and TGF–β (1) | Andragogy (1) | Andrographolide (1) |
| Anemia (3) | Anethole (1) | Anethum graveolens (1) |
| Aneurysm (1) | Angiogenesis (1) | Angiogenic growth factors (1) |
| Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) | Animal Models (1) |
| Ankylosing spondylitis (1) | antepartum (1) | anthelmintic (1) |
| anthelmintic property (1) | Anthocyanin (1) | Anthracyclines (2) |
| Anti aging (1) | Anti hyperglycemic (1) | Anti inflammatory (1) |
| Anti-amnesia (2) | anti-anxiety activity (2) | Anti-anxiolytic (1) |
| Anti-asthmatic activity (1) | Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) |
| Anti-diabetic drugs (1) | Anti-diabetics (1) | Anti-eczema drugs (1) |
| Anti-epileptic (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (2) |
| anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
| anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
| anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
| anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
| Anti-oxidant (2) | Anti-parkinsonism activity (1) | Anti-solvent (1) |
| anti-spasmodic drug (1) | Anti-TB drugs (1) | Anti-tubercular activity (1) |
| Anti-tumor agent (1) | antiamnesic agents (1) | Antianxiety (1) |
| antibacterial (3) | antibacterial activity (5) | Antibacterial drugs (1) |
| Antibiotic (2) | Antibiotic Drug utilization (1) | antibiotic guidelines (1) |
| Antibiotic paste (1) | Antibiotic Resistance (5) | Antibiotic Sensitivity (1) |
| Antibiotic stewardship (1) | Antibiotics (13) | Antibiotics. (1) |
| Anticancer (6) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (3) | Anticoagulant service (1) |
| anticonvulsant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
| Antidiabetic (3) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| Antiepileptic (1) | antiepileptic agents (1) | Antiepileptic Drugs (3) |
| Antifibrinolytic. (1) | antifungal (1) | antifungal activity (1) |
| Antifungal drugs (1) | Antigen (1) | antigen protein (1) |
| Antiglycation (1) | Antihistaminic (2) | Antihyperglycemic (1) |
| Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
| Antimalarial (2) | Antimicrobial (5) | Antimicrobial activities (1) |
| Antimicrobial activity (7) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
| Antimicrobial Plants (1) | Antimicrobial resistance (3) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) |
| Antimicrobial Stewardship (1) | Antimicrobials (4) | Antimosquito (1) |
| Antimycotic Activity (1) | antinociceptive (1) | Antioxidant (22) |
| Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (10) | antioxidant effect (1) |
| Antioxidant properties (1) | Antioxidants (6) | Antiplatelet (1) |
| Antiplatelet and anticoagulant therapy. (1) | Antipsychotics (2) | antipyretic (2) |
| Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antiretrovirals (1) |
| Antispasmodic (1) | Antithrombotic (2) | Antithyroid drugs (1) |
| Antitubercular (1) | Antitubercular activity (1) | Antitubercular drugs. (1) |
| antiulcer (1) | Antiurolithiatic activity (3) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (2) | antiviral activity (2) |
| Antiviral RNA (1) | Anti– microbials (1) | Anxiety (5) |
| Anxiety disorder (1) | Anxiolytics (1) | APAP (1) |
| APC (1) | Aphthous stomatitis /ulcer (1) | Apoptosis (3) |
| Application (1) | Application to PK profile studies (1) | applications (1) |
| Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
| Arabic gum (1) | ARBs (1) | ARDS (1) |
| Area above the blood glucose levels-time curve. (1) | area of wound healing (1) | Areca nut (1) |
| Arginase (2) | Arginine (1) | Aripiprazole (1) |
| Armodafinil (1) | ART (1) | Artemia salina (1) |
| Artemia salina. (1) | Artemisia (1) | Artemisia absinthium (1) |
| Artemisia macrocephala (1) | arterial hypertension (1) | Arterial stiffness (2) |
| Arteriovenous malformation (AVM) (1) | Arthralgia (2) | Arthritis (1) |
| Artificial intelligence (1) | Artificial Neural Networks (1) | ARV Drugs (1) |
| Ascorbic acid (3) | ASEAN (1) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus (1) |
| Asparagus racemosus root extract (1) | Aspergillus niger (2) | Aspergillus niger. (1) |
| Aspergillus terreus (1) | Aspirin (2) | Assay (2) |
| Assessment (1) | astasia (1) | Asthma (6) |
| Asymptomatic neurocognitive impairment (1) | Ataxia (5) | ATC/DDD (3) |
| Atenolol (1) | Atherosclerosis (1) | Atherosclerotic Vascular Disease (1) |
| Athlete Biological Passport (1) | Atorvastatin (5) | Atorvastatin calcium (1) |
| Atorvastatin. (1) | ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) |
| Atractylis flava Desf (1) | Atrial fibrillation (1) | Atropine (1) |
| Attitude (9) | Attitude and practice (1) | Attitude. (1) |
| Attitudes (2) | Attitudes and Practice in Health (1) | Atypical antipsychotics (1) |
| Aubacute toxicity (1) | Aucubin (1) | Authors (1) |
| Authorship issues (1) | Autism spectrum disorders (1) | Auto antibody (1) |
| Auto medication (1) | Autodock Vina. (1) | Autoimmune disease (1) |
| Autoimmune disorders (1) | Autoimmunity (1) | Averrhoa bilimbi (1) |
| Avicel (1) | AWaRe Classification (1) | Awareness (7) |
| Ayurveda (2) | Ayurvedic (1) | Azelaic acid (1) |
| Azilsartan medoxomil (1) | B cell epitope (1) | Back pain (1) |
| Bacoside A3 (1) | Bacteremia (1) | Bacteria (2) |
| Bacterial contamination (1) | Bacterial isolates (2) | Bacteriological culture (1) |
| Bacteriostatic (1) | Baker Venkataraman transformation (1) | Bamboo betung (1) |
| Bambusa vulgaris (1) | Banana (1) | Bangladesh (3) |
| bark (1) | Barleria cristata (1) | Barriers (1) |
| Bauhinia purpurea (1) | Bauhinia racemosa (1) | Bauhinia variegata (2) |
| Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) | BCG vaccine (1) |
| BCS-IV drug (1) | Beauty Salon Owner (1) | Beck Depression Inventory (1) |
| Beck Depression Inventory(BDI) (1) | Bedaquiline (1) | Behavioral research (1) |
| Behaviour (1) | Belief (2) | Benchmarking (1) |
| Benzimidazole derivative (1) | benzimidazoles (2) | Benzodiazepines (1) |
| Benzothiazole analogues (1) | Benzo[d]oxazole-2-thiol (1) | Berberis integerrima Bunge (1) |
| Beta-lactamase (1) | Beta-lactamic (1) | Bibliographic characterstics (1) |
| BIbliometric. (1) | Bibliometrics (18) | Bibliometrics. (3) |
| BIBN4096 (1) | Bilayered floating tablets (1) | Bioactive compound (1) |
| Bioactive Metabolites (2) | Bioactivity (1) | Bioadhesive (1) |
| Bioanalytical (2) | Bioanalytical method (2) | Bioanalytical method development (1) |
| Bioassay (1) | bioavailability (8) | Biodegradable (1) |
| Bioethics (1) | Biofilm (1) | Biohazard (1) |
| Biologics (1) | Biology (1) | Biomarker (2) |
| Biomaterials (1) | Biomedical (1) | Bioprospecting. (1) |
| Biopsy Proven Acute Rejection (1) | Biosafety (1) | Biosafety Engineering Control (1) |
| Biosimilars (2) | Biotechnology (2) | Bipolar affective disorder drugs (1) |
| Bisphosphonates (2) | Bitter (1) | Black Garlic (1) |
| Black tea extract (1) | BLAST (1) | Bleaching (1) |
| Bleeding time (1) | Bleomycin (1) | Blonanserin (1) |
| Blood brain barrier (1) | Blood donor (1) | Blood glucose (1) |
| Blood groups (1) | Blood pressure (4) | Blood safety (1) |
| Blue and red from (1) | Body Mass Index (1) | Body Mass Index (BMI). (1) |
| Boerhaavia Diffusa (1) | Bone (2) | Book Review (1) |
| Borg scale (1) | botulinum toxin (1) | Box-Behnken (1) |
| Bpharm (1) | Brahmi vati (1) | Brain (1) |
| Brain targeting (2) | Braindisoders (1) | Brand Drugs (1) |
| brand name drugs (1) | Branded drugs (1) | Branded medication (1) |
| Branded medicine (1) | Bratton-Marshall reagent (1) | Brazil (1) |
| Breast cancer (6) | Breast Feeding (1) | Breastfeeding (2) |
| Brewer’s yeast (1) | Brief COPE scale (1) | Brief medication questionnaire (1) |
| Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) |
| Broad spectrum antibiotics (1) | Brochures (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (2) |
| Bruxism and Dentistry (1) | Bryonia laciniosa (1) | Buccal (1) |
| Buccal Patches (1) | budget forecasting (1) | Bufadienolide (1) |
| Bullous eruption (1) | bungarotoxin (1) | Bungarus caeruleus (1) |
| Bungur (1) | Buni-berry extract (1) | Buoyancy (1) |
| Buoyant microspheres (1) | Burden Of Disease (1) | Burn wound (1) |
| Business method (1) | Business model (1) | Butea monosperma (1) |
| C-reactive protein (1) | C. albicans (1) | C60 derivatives (1) |
| C934 (1) | CA125 (1) | Ca2+ channels (1) |
| Cadmium chloride (1) | Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) |
| Caesalpinia pulcherrima (L.) Sw. stem bark (1) | Caesalpinia sappan (1) | CAGR (1) |
| Calcineurin inhibitor (1) | Calcium (2) | Calcium channel blocking (1) |
| calcium channel blocking activity (1) | Calcium oxalate (1) | Calcium phosphate (1) |
| Calcium silicate (1) | Calendula officinalis (1) | calendula oil (1) |
| CAM Assay (1) | Camelia sinensis extract (1) | Camellia sinensis (1) |
| Camptothecin (1) | Canagliflozin (1) | Cancer (7) |
| Cancer Chemotherapy (2) | Cancer treatment (1) | Candida (2) |
| Candida albicans (4) | Candida albicans. (1) | CaOx crystal aggregation (1) |
| CaOx crystal nucleation (1) | CAP-e (1) | Capacity (1) |
| Capsule (1) | capsules (1) | carbamazepin (1) |
| Carbamazepine (4) | carbohydrazide (1) | Carbomyl Linkage (1) |
| carbon tetrachloride (2) | carbonyl compounds (1) | Carbopol (1) |
| Carbopol 940 (1) | Carcinogenic substances (1) | Carcinoma. (1) |
| cardiac arrhythmias (1) | Cardiac care (1) | Cardiac complication (1) |
| Cardiac remodeling (1) | Cardiology (2) | Cardiology. (1) |
| Cardioprotection (1) | Cardioprotective (1) | Cardiotoxicity (2) |
| Cardiovascular disease (2) | Cardiovascular drugs (1) | Cardiovascular Outcomes (1) |
| Career Choices (1) | Carica papaya L. (1) | Carnaúba (1) |
| Carnauba wax (1) | carrageenan (2) | Caryocar coriaceum (1) |
| Case report (1) | Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) |
| Catalase (1) | catalepsy (2) | Cation-pi (1) |
| CationicGuargum (1) | Caulerpa lentillifera (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CCl4 (1) |
| CD150 (1) | CD244.2 (1) | CD48 (1) |
| Cefixime (1) | Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) |
| Cefuroxime (1) | Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) |
| Cellulase (1) | Cellulite (1) | Cellulitis (1) |
| Cellulose (2) | Cemented (1) | Cementless (1) |
| CEN (1) | Centella asiatica (3) | Central composite design (4) |
| Central cord syndrome (1) | Central post-stroke pain (1) | Cephalexin (2) |
| Ceramics (1) | Cerebellar ataxia (1) | Cerebellar atrophy (1) |
| Cerebellar nuclei degeneration. (1) | Cerebrospinal Fluid. (1) | Cerebrovascular Accident (1) |
| Cerebrovascular Disorder (1) | Cervical bulge (1) | Cervical dentine hypersensitivity (1) |
| Cervical lymphadenopathy (1) | CFFF (1) | CGRP (1) |
| chalcone (1) | chalcones (3) | Challenges (1) |
| Chamomile tea (1) | Characterization (4) | Chebulinic acid (1) |
| Chemical stability (1) | Chemiluminescence (1) | Chemomechanical removal (1) |
| Chemometrics (3) | Chemotaxis (1) | Chemotherapy (7) |
| Chewable tablets (1) | Chewing gum (1) | Child Care (1) |
| Childhod (1) | Childhood cancer (1) | Children (4) |
| Children and youth (1) | Children Dentistry (1) | Children. (2) |
| Chitin (1) | Chitosan (8) | Chitosan Acetate. (1) |
| chitosan microspheres (1) | Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) |
| Chlamydomonas reinhardtii (1) | Chloramphenicol (1) | Chlorhexidine (2) |
| Chlorohexidine (1) | cholesterol (1) | Cholesterol HDL (1) |
| Cholinesterase inhibitors (1) | Chromatography (2) | Chromotropic acid reagent (1) |
| Chronic disease (1) | Chronic Heart Failure (1) | Chronic hepatitis B (1) |
| Chronic kidney disease (2) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chronic Periodontitis (1) |
| Chronic use (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
| Cigarette smoke (1) | Cilostazol (1) | Cinnamaldehyde (1) |
| Cinnamic acid derivatives (1) | Cinnamomum cassia (1) | Ciprofloxacin (2) |
| Citronella (1) | Citrus hystrix (1) | Citrus limon (2) |
| CKD (1) | CKMB. (1) | Claims (1) |
| Clarithromycin (1) | Classification (1) | Clastogenicity (1) |
| Cleistanthin A (3) | cleistanthin B (3) | Cleistanthus Collinus (2) |
| Clinic Epidemiology (1) | Clinical attachment (1) | Clinical attachment level (1) |
| Clinical efficacy (1) | Clinical equivalence (1) | Clinical manifestation (1) |
| Clinical perspective (1) | Clinical Pharmacist (1) | Clinical pharmacist care (1) |
| Clinical pharmacist intercession (1) | Clinical Pharmacists (1) | Clinical pharmacology (1) |
| Clinical Pharmacy (1) | Clinical Pharmacy Services (1) | Clinical research (1) |
| Clinical symptoms (1) | Clinical trial (1) | Clinical trials (1) |
| Clinicians (1) | clonidine (2) | Clopidogrel (1) |
| Clopidogrel bisulfate (1) | Closed melt (1) | Clove (1) |
| cloxacillin (1) | Cluster analysis (1) | CME (1) |
| CNC (1) | CNF (1) | CNS stimulants (1) |
| Co-crystal (1) | Co-Formers (1) | Co-grinded mixture (1) |
| Co-morbidities (1) | Co-Morbidity (1) | Co-morbidity. Correspondence (1) |
| co-precipitation method (1) | Co-surfactant (1) | Cochlopermum tinctorium (1) |
| coding system (1) | Cognition (2) | Cognitive impairment (1) |
| Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
| Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colon targeting (1) |
| Colonic delivery (1) | Colonoscopy (1) | Colorectal cancer (1) |
| colorimetric assay (1) | Column chromatography (1) | Combination tablet (1) |
| Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
| Common Carp (1) | common cold (1) | common cold and cough (1) |
| Common warts (1) | Communicable Disease Control (1) | Community Pharmacies (2) |
| Community pharmacist (3) | Community Pharmacists (2) | Community pharmacy (3) |
| Community Pharmacy Patient Questionnaire (1) | Community Pharmacy Services (1) | Comorbid (1) |
| Comorbidity (1) | Comparative dissolution (1) | comparative molecular similarity indices (1) |
| comparative molecular Þ eld analysis (1) | Comparison (1) | compensation (1) |
| Complementary and alternative medicine (2) | complementary and alternative medicines (1) | Complementary and alternative therapy (1) |
| complete epithelization (1) | Complexation (1) | Compliance (1) |
| Complications (1) | compound 48/80 (2) | compritol 888 ATO (1) |
| Computer (1) | Computer literacy (1) | computer-aided instructions (1) |
| Computer-aided learning (1) | Computerized screening systems (1) | Computing methods (1) |
| CoMSIA (1) | Cone-beam tomography (1) | Conessine (1) |
| Congenital infection. (1) | Conjugation (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | Consumer side effects reporting from (1) |
| Consumer’s Perception (1) | Content validation (1) | content validity (1) |
| continuing education (2) | Continuous Pharmacy Education. (1) | Contract research (1) |
| Contract research organizations (1) | Control (1) | Controlled release (4) |
| Convenience (1) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
| Cordia obliqua (1) | Corneal bacterial ulcers (1) | Corneal opacities (1) |
| Coronally advanced flap (1) | Coronavirus (1) | Coronavirus disease (1) |
| Coronavirus disease 2019 (3) | Correlation (2) | Corticosteroid (2) |
| Corticosteroids (2) | Cosmetic (2) | Cosmetic products (1) |
| Cosmetics (1) | Cosmetics use-related adverse reactions (1) | Cosolvency (1) |
| Cost analysis (1) | Cost avoidance (1) | Cost Minimization (1) |
| Cost of illness (2) | Cost saving (1) | Cost-effectiveness analysis (1) |
| Cost. (1) | Costing Analysis. (1) | Cotton dust (1) |
| Cotton oil (1) | cotton pellet (1) | Cough (1) |
| Cough medicine (1) | cough. (1) | Counterfeit Pharmaceutical Products (1) |
| Counterfeiting (1) | COVID -19 (2) | COVID-19 (20) |
| COVIID 19 (1) | CPs (1) | Cramer’s Matrix method (1) |
| CRC (1) | Cream (1) | creatinine (1) |
| Crinum asiaticum (1) | CRISPR/Cas9 (1) | Critical Care Unit (CCU) (1) |
| Critical Material attributes (1) | Critical material attributes (CMAs) (1) | Critical Quality Attributes (1) |
| Critical quality attributes (CQAs) (1) | Critical Thinking (1) | cromolyn sodium (1) |
| Cronbach’s alpha (1) | Croscarmellose sodium (CCS) (1) | Crospovidone (1) |
| Crospovidone (CP) (1) | Cross carmellose sodium (1) | cross-linking agents (1) |
| Cross-sectional study (1) | Crossandra (1) | Croton zehntneri (2) |
| Crystallinity (2) | CTCAE (2) | CTEPH (1) |
| Cucumis metuliferus (1) | Cucumis sativus (1) | Culex quinquefasciatus (1) |
| CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
| Curcumin (4) | current indian scenario of drug interactions (1) | Curriculum (1) |
| curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) | Cutaneous manifestation (1) |
| Cutaneous reaction (1) | CXCR4 (1) | Cyclodextrin (1) |
| Cyclooxegenase-2 inhibitor (1) | Cyclooxygenase (2) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyprinus carpio (1) | Cyst (1) | Cytochrome P 2C9 (1) |
| Cytokine (1) | Cytosine (CYS) (1) | Cytotoxic (1) |
| Cytotoxic activity. (1) | Cytotoxic agents (1) | Cytotoxicity (4) |
| CZE (1) | D&C (1) | D-optimal design (1) |
| Daily Defined Dose (1) | Dammam (1) | Dapsone (1) |
| DASS-21 scale. (1) | Data mining algorithms (1) | DCA (1) |
| DDD (1) | DDX3 (1) | Death Receptors (1) |
| Decaschistia crotonifolia Wight and Arn. (1) | Decision making (1) | Deep vein thrombosis (1) |
| deferasirox (1) | deferiprone (1) | Deficiency (1) |
| Definitive screening design (DSD) (1) | Degenerative disc disease (1) | Degradation (1) |
| Degradation studies (1) | Dehydrozingerone (1) | Delignification (1) |
| Delirium (2) | Dementia (1) | democratic government (1) |
| Dengue (1) | Dengue high fever (1) | Dental caries (5) |
| Dental Caries. (1) | Dental decay (1) | Dental implants (2) |
| dental management (1) | Dental Prosthesis (2) | Dental prosthesis. (1) |
| Dental Restoration (1) | Dental Students (1) | Dentistry (3) |
| dentistry. (1) | Dentists (1) | Denture Stomatitis (1) |
| Deodorants (1) | Dependence (1) | Depigmentant (1) |
| Depok Primary Health Care (1) | Deprescribing (1) | Depression (5) |
| Depression 1 (1) | Dermatology (1) | Dermatology life Quality Index (1) |
| Dermatology. (1) | Dermic implants (1) | Design of experiments (DoE) (1) |
| Design of experiments. (1) | desirability function (1) | Desirability index. (1) |
| Desmodium gangeticum (1) | Desolvation Method (1) | Detorsion (1) |
| Deuterium (1) | Developmental regression (1) | device safety (1) |
| dexamethasone (2) | Dexibuprofen (1) | Dextrin (1) |
| DIA (1) | Diabetes (9) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (17) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | Diabetes. (1) | Diabetic (1) |
| diabetic dyslipidemia (1) | Diabetic nephropathy (1) | Diabetic retinopathy (1) |
| Diabetic Wound (1) | Diacerein (1) | DiaKure (1) |
| Diazepam (1) | diclofenac (2) | Diclofenac SLN (1) |
| Diclofenac sodium (1) | Dicloxacillin sodium (1) | Dicots (1) |
| Dicyclomine (1) | differential scanning calorimetry (1) | diffuse transmittance (1) |
| Diffusion method (1) | Digital marketing (1) | Dillenia indica (2) |
| Dilleniaceae (1) | Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) |
| Dimethylpyrimidin-derivatives (1) | Dip coating (1) | Diplotropis ferruginea (1) |
| direct compression (3) | Direct to consumer advertising (1) | Directly observed treatment short-course (1) |
| Directly observed treatment shortcourse (1) | Discharge against medical advice (DAMA) (1) | discharge orders (1) |
| DISCLE (1) | Discrepancies (1) | Discriminant analysis (1) |
| Disease (1) | Disease free survival (1) | disintegration (1) |
| disintegration time (1) | Disproportionality Analysis (1) | Dissolution (5) |
| dissolution enhancement (1) | Dissolution rate (1) | Diuretic (1) |
| Diuretic activity (2) | Diuretics (1) | DMAIC (1) |
| DMH (1) | DNA barcoding (1) | DNA damage (1) |
| DNA fragmentation (1) | docking (7) | Docking studies (2) |
| docking. (1) | Doctor (1) | Documentation (1) |
| Documentation and records (1) | Donepezil hydrochloride (1) | Dopamine (1) |
| Dosage formulation (2) | Dosage regimen (1) | Dose-dependent (1) |
| Dossier. (1) | DOTS (1) | DOTS plus (1) |
| Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
| DPP-IV (1) | DPPH Assay (1) | DPPH radical scavenging assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| DRESS syndrome (1) | Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) |
| droplet size (1) | Droplet-based Bioprinting (1) | Drug (2) |
| Drug allergy tests (1) | Drug carriers (1) | Drug delivery (3) |
| Drug delivery denture (1) | Drug Design (1) | Drug detailing (1) |
| Drug Discovery (1) | drug disposal (2) | Drug drug interactions (1) |
| Drug Hypersensitivity (2) | Drug induced nephrotoxicity (1) | Drug Information and Literature Evaluation (1) |
| drug interaction (2) | Drug interaction (DI) (1) | drug interaction management (1) |
| Drug Interaction probability scale (1) | drug interactions (3) | Drug Policies (1) |
| Drug prescriptions (1) | Drug product (1) | Drug regimens (1) |
| Drug Related Problems (4) | Drug related side effects (1) | drug release (1) |
| Drug Resistance (2) | Drug risk ratio (1) | Drug safety (3) |
| Drug Safety. (2) | Drug therapy (1) | Drug utilisation patterns (1) |
| Drug utilization (3) | Drug utilization pattern (1) | Drug utilization review (1) |
| drug utilization study (1) | Drug utilization. (1) | Drug-drug conjugate (1) |
| drug-drug interactions (5) | Drug-related problem (2) | Drug-Related Side Effects and Adverse Reactions (1) |
| Drug-SLS tablets. (1) | Drugedrug interaction (1) | Drugs (3) |
| Drugs and Cosmetics rules (1) | Drugs of abuse (1) | drug–drug gliclazide (1) |
| Drug–drug interaction (1) | Dry extract cinnamon (1) | Drying techniques (1) |
| DSPC (1) | Dual approach. (1) | Dual control release (1) |
| Dual Therapy (1) | dual-target-directed drugs (1) | Dunaliella salina (1) |
| Dynamic (1) | Dyslipidemias (1) | Dysphagia (1) |
| E learning (1) | E-Cigarettes (1) | E-learning (1) |
| E-pharmacy websites (1) | e-prescribing (1) | E. coli (1) |
| E.crispa (1) | Early childhood caries (1) | Early-Related Complications (1) |
| Eastern province (2) | Ebanaceae (1) | EC50 values (1) |
| Economic (1) | Economic burden (1) | Eczema (1) |
| Edaravone (1) | Eddy’s hot plate method. (1) | edema (1) |
| Edible flowers (1) | Editorial (24) | Education (3) |
| Education material (1) | Educational excellence (1) | efavirenz (2) |
| Effectiveness. (1) | Efficacy. (1) | EGCG (1) |
| Egfr (1) | egg albumin microspheres (1) | Elderly (1) |
| Elderly Patients (1) | Electrochemical (1) | electrolyte release (1) |
| electrolytes (1) | Electron beam radiation (1) | Electronic prescribing (1) |
| Electronic prescription (1) | Electroporation (1) | Elemental analysis. (1) |
| Elevated plus maze (2) | elevated plus maze model (1) | Elevated plus-maze (1) |
| Elisa (1) | Ellman’s assay (1) | Emblica offi cinalis (1) |
| Emergency contraception (1) | Emodin (1) | Emotional (1) |
| Emotional domain (1) | Emulgel (2) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encapsulation (2) |
| Encholirium spectabile (1) | Endocrine disruptor (1) | Endogenous insulin (1) |
| Endophytes (1) | Endothelial cells (1) | endothelial Nitric Oxide Synthase (1) |
| Endothelial progenitor cells (1) | Endothelium (1) | Endothelium. (1) |
| Enhanced patient care (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental domain (1) | Environmental Factors (1) | Environmental factors. (1) |
| Environmental Sciences (1) | Enzymatic hydrolysis (1) | Enzyme kinetics (1) |
| eosinophil (1) | EPDS scale (1) | Epicatechin (1) |
| Epidemic (1) | Epigallocatechin (1) | Epigallocatechin Gallate (2) |
| Epigallocatechin gallate (EGCG) (1) | Epigenetics (1) | epilepsy (6) |
| Epithelial ovarian cancer (1) | Epithelization (1) | EQ-5D-5L (1) |
| EQ5D (1) | ER Matrix (1) | erbal drugs (1) |
| erice declaration (1) | Erythema (1) | Erythema multiforme (1) |
| Erythrina indica (1) | Erythrina variegata (1) | Erythrocyte sedimentation rate (1) |
| Erythroderma (1) | erythropoietin (2) | Escherichia coli (1) |
| Escitalopram oxalate (1) | ESI (1) | esomeprazole (1) |
| Essential drugs (1) | Essential hypertension (2) | Essential medicine (1) |
| essential medicines (2) | essential oil (5) | essential oil composition (1) |
| Essential principles (1) | Esthetics Dental (1) | Estimated Glomerular Filtration Rate (1) |
| Estrogen receptor alpha (1) | Ethambutol (1) | Ethanol (1) |
| Ethanol extract (1) | ethanolic extracts (1) | Ethiopia (2) |
| ethnicity (2) | Ethnomedicine (2) | Ethnopharmacy (1) |
| Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) |
| Ethyl acetate fraction (1) | ethyl cellulose (2) | ethylcellulose (3) |
| ethylene glycol (2) | Etiology (1) | Eucalyptus (1) |
| Eucalyptus hybrid (1) | Eucalyptus oil (3) | eudragit (2) |
| Eudragit RL 100 (1) | eudragit S100 (2) | Eudragit-L100 (1) |
| Eudragit® S100 (1) | Eugenol (1) | Euphorbia hirta leaves (1) |
| Eurycoma Longifolia Jack (1) | Evaluation (1) | EVD (1) |
| Ex vivo tissue entrapment (1) | ex-vivo performance (1) | Ex-vivo permeation (1) |
| Ex-vivo study (1) | Exacerbation (1) | Excess Alcohol Consumption (1) |
| Excision wound model (1) | Expectoration (1) | Experience (1) |
| experiences (1) | Experiential learning (1) | Experimental ischemic stroke (1) |
| experimental study (1) | Expired medicines (1) | Expiry drugs (1) |
| Exports (1) | Expression profile (1) | Extract (1) |
| Extrapyramidal side-effects (1) | extrinsic stains (1) | extrusion (1) |
| Extrusion-Based Bioprinting (1) | Eye lens (1) | Ezetimibe (2) |
| Fabaceae (2) | Facial implants (1) | Facial Pain (1) |
| Factor analysis (1) | factorial design (5) | Factors (1) |
| Factors associated with medication non-adherence (1) | Falcipain-2 (1) | Fall-risk increasing drugs (1) |
| Falls (1) | Family Planning Services (1) | Family satisfaction (1) |
| family therapy (1) | famotidine (2) | fast disintegrating tablet (1) |
| Fast Disintegrating Tablets. (1) | Fast dissolving film (1) | Fast dissolving films (1) |
| Fast dissolving tablets (1) | Fasting serum insulin level (1) | Fat (1) |
| Fatty acid profile (1) | FC reagent (1) | FDA AERS Database (1) |
| FDA Approval (1) | Fenugreek (1) | Ferric reducing antioxidant power assay (1) |
| Ferritin (1) | Ferrous sulfate (1) | Fetal Case Report (1) |
| Fever (1) | Fialuridine', (1) | Ficus bengalensis (1) |
| Ficus bengalensis (Moraceae) (1) | Ficus deltoidea (1) | Ficus racemosa (1) |
| film (1) | film hydration (1) | Fine needle aspiration cytology (1) |
| First permanent molars (1) | Fixed drug eruption (1) | Flavone (1) |
| Flavonoid (3) | Flavonoid Compounds (1) | Flavonoid fraction (1) |
| flavonoids (3) | Flavoxate HCl (1) | FlK-1 (1) |
| Floating beads (1) | floating controlled drug-delivery system (1) | Floating Drug Delivery (1) |
| Floating drug delivery system (1) | floating lag time (1) | Floating tablets (1) |
| Floriculture (1) | Flow cytometry (1) | Flue (1) |
| fluoroquinoes (1) | Fluoroquinolones (1) | Fluoxetine (1) |
| Flupritine maleate (1) | flurbiprofen (1) | Flux (2) |
| FMCG (1) | folkloric use (1) | Follow up treatment (1) |
| Food drug and cosmetic act (1) | Forced degradation (4) | Forced degradation studies (1) |
| forced swim test (1) | Formication (1) | Formulary (1) |
| Formulary. (1) | Formulation (6) | Formulation and development (1) |
| Formulation Development. (1) | Fortification (1) | Fortified antibiotics (1) |
| Fourier transform infra red spectroscopic (1) | FPG (1) | FPGEE (1) |
| Fraction (1) | Franz Diffusion Cell (3) | FrEA5 (1) |
| free radical scavenger (1) | Free radicals. (1) | Freeze-drying (1) |
| Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) |
| Frusemide-induced complications (1) | FTIR (5) | Full coverage occlusal plaques (1) |
| Fullerenes (1) | Fumes (1) | functions (1) |
| Fungal infections (1) | furosemide (1) | Future Health Care Professionals (1) |
| Future healthcare professionals (1) | Future plans (1) | G6PD deficiency (1) |
| GABA (2) | Gabapentin (1) | Galacto-Oligosaccharide (GOS) (1) |
| Galic Acid (1) | gallic acid (3) | Galphimia glauca Clav (1) |
| Gamma irradiation (1) | Gamma scintigraphy (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
| Garcinia imberti (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
| Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
| Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
| GDP (1) | Gelatin (1) | Gelling Capacity. (1) |
| Gels (1) | Gemcitabine HCl (GCH) (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene modification (1) | Gene silencing (1) |
| General medicine (1) | Generic (2) | generic drugs (4) |
| Generic Medicine (2) | Generic medicines (2) | Generic name. (1) |
| Generic substitution (1) | Generics (1) | Genetic polymorphisms (1) |
| genetic Signature (1) | Genotoxin (1) | Genotype frequency (1) |
| Gentamicin (6) | gentamicin sulfate (2) | Geriatrics (3) |
| Gewald’s reaction (1) | GFAP (1) | Gibb’s reagent (1) |
| Gina criteria (1) | Ginger (1) | Gingival hyperplasia (1) |
| Gingival hypertrophy (1) | gingival pocket (1) | Gingival recession (1) |
| Gingival thickness (1) | Gladiolus segetum (1) | glibenclamide (5) |
| gliclazide (2) | Glidescore (1) | Glimepiride (2) |
| glimepride (1) | Glipizide (3) | glitazars (1) |
| Global (1) | Global education (1) | Global Papers (1) |
| Global publications (7) | Glomerulonephritis (1) | Glucagon (1) |
| Glucocorticoids (1) | Glucosamine (1) | Glucosamine sulphate (1) |
| Glucose (1) | Glucose metabolism (1) | glucose tolerance test (1) |
| glutathione (1) | Glycemic Control (1) | Glycerin (1) |
| Glycerine (1) | Glyceryl monostearate (1) | Glycine max (1) |
| Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) |
| Goal orientation (1) | Goldenhar syndrome (1) | good manufacturing practices (1) |
| Google docs (1) | Gotu kola leaves extract (1) | Government sector (1) |
| GPx (1) | Graft Rejection (1) | Graft Survival (1) |
| Grafting (1) | Grafts (1) | Gram negative (1) |
| Gram negative bacteria (1) | Gram positive (1) | Gram positive bacteria (1) |
| Gram-Negative Organisms (1) | Gram-Positive Organisms (1) | Granulomatous Vasculitis (1) |
| Grape seed extract (1) | Grape seed oil (1) | Grapes seed extract (1) |
| Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
| Green Tea Leaves Extract (2) | Grip strengthening test (1) | Griseofulvin (1) |
| GSH (2) | Guanidine Moiety (1) | guanyl cyclase stimulator (1) |
| Guest Editorial (1) | Guidelines (1) | Guinea pig (1) |
| Gulf cooperation council (1) | Gum and fat fractions (1) | Gum arab (1) |
| Gymnema Sylvestre (2) | Gynura procumbens (1) | Gypsum (1) |
| GYTS (1) | H+ (1) | H-460 (1) |
| H2 Receptor Antagonist (1) | H2O2 (1) | HAART (1) |
| Habits (2) | Haematological (1) | Haematuria (1) |
| Haemoglobin (1) | Haemolysis (1) | Haemolytic ratio. (1) |
| Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (2) | Hand and Foot Syndrome (1) |
| hardness (1) | Haritaki (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hartwigs Severity Assesment Scale (1) | Haryana (1) |
| Hazardous drugs (1) | HbA1C (2) | HBV (1) |
| HCT: Hydrocholrothiazide. (1) | HDAC4 (1) | HDAC7 (1) |
| head twitch (1) | Health benefits (1) | Health Care Coordination and Monitoring (1) |
| Health Care Costs (1) | Health care profession (1) | health care professionals (1) |
| health care students (2) | Health care. (1) | Health Education (1) |
| Health Expenditures (1) | Health for All (1) | Health Hazard (1) |
| Health informatics (1) | Health Information Technology (1) | Health Knowledge (1) |
| Health problems (1) | Health Professionals (1) | Health Professions Students (1) |
| Health related quality of life (2) | Health risks (1) | Health Services Accessibility (1) |
| Health Status Indicators (1) | Health Surveillance (1) | Healthcare (5) |
| healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
| Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
| heart failure (4) | Heart failure clinics (1) | Heart Failure Hospitalization (1) |
| Heat-shock (1) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | Hematopoietic progenitors (1) |
| Hemodialysis (2) | Hemoglobin (1) | Heparin (1) |
| hepatic impairment (2) | Hepatic marker (1) | Hepatitis (1) |
| Hepatitis B (1) | Hepatitis B virus core protein (1) | Hepatocellular (1) |
| Hepatocurative (1) | hepatoprotective (4) | hepatoprotective activity (3) |
| Hepatotoxicity (1) | HER1 (1) | HER2 (1) |
| HER3 (1) | HER4 (1) | Herbal active ingredients (1) |
| Herbal drugs (1) | Herbal formula (1) | Herbal medications (1) |
| Herbal medications. (1) | Herbal medicine (2) | herbal medicines (1) |
| Herbal therapy (1) | Herbaldb (1) | HET-CAM (1) |
| Heterocyclic compound (1) | Heterotopic Pregnancy (1) | Hex (1) |
| Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
| Hidradenitis suppurativa (1) | High fat diet (2) | High Fat Diet Model (1) |
| High impact resin (1) | high performance liquid chromatography (1) | high performance thin layer chromatography (1) |
| High-Cited Papers (3) | High-Cited Publications (1) | High-density lipoprotein cholesterol (1) |
| High-fat diet (1) | high-performance liquid chromatography (2) | High-throughput screening (1) |
| Higher education (1) | highly active antiretroviral therapy (1) | Highly Cited Papers (1) |
| Himatanthus drasticus (1) | Hip Arthroplasty (1) | Hirsutism (2) |
| Histocompatibility. (1) | Histological studies. (1) | Histopathological studies (1) |
| Histopathology (3) | HIV (3) | HIV associated dementia. (1) |
| HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) |
| HL-60 and K-562 (1) | HLA (1) | HMG-CoA Reductase (1) |
| Homalium zeylaicum (1) | Homeopathic medicines (1) | Homeopathy (1) |
| homology modeling (1) | Honey (1) | Honeycomb (1) |
| Hordeum vulgare (1) | Hordeum vulgare hull (1) | Horticulture (1) |
| Hospital pharmacy (2) | Hospital Services (1) | hospitalized children (1) |
| hospitalized patients (1) | Hospitals (1) | host (1) |
| Host-guest interactions (1) | hot plate (1) | HP-ß Cyclodextrin complexes (1) |
| HPLC (9) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) |
| HPLC. (1) | HPMC (1) | HPMC capsules (1) |
| HPMC K100M (2) | HPMC K4M (1) | HPTLC (7) |
| HPTLC Fingerprinting (1) | HQLQ (1) | HRQoL (3) |
| HSV-1 (1) | Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) |
| human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) | Human Papillomavirus (1) |
| Human plasma (2) | human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) |
| Humanitarian device exemption. (1) | Humours (1) | Hyaluronic acid (1) |
| Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) | Hydroalcoholic (1) |
| hydrochlorothiazide (2) | Hydrochlorthiazide (1) | hydrogel (2) |
| Hydrogels (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
| Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
| Hydrotrophy (1) | hydroxy propyl methyl cellulose (1) | Hydroxyapatite (1) |
| Hydroxyl radical (1) | Hydroxyproline (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (2) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| Hypersensitivity (1) | Hypersensitivity reaction (2) | hypertension (11) |
| Hypertension( HTN) (1) | Hypertensive’s (1) | Hyperthyroidism (1) |
| hypertriglyceridemia (2) | Hypertrophy (1) | Hyperzincuria (1) |
| Hyphenated system (1) | hypoglycemic (1) | Hypoglycemic activity (1) |
| hypolipidemic (1) | Hypomineralization (1) | Hypothyroidism (1) |
| Hypozincaemia (1) | Iatrogenic dermatological reaction (1) | IBD (1) |
| IBD - Inflammatory Bowel Disease (1) | IBS (1) | IC50 (2) |
| ICH (2) | ICH guidelines (3) | ICP22 (US1) gene (1) |
| Idiopathic Thrombocytopenia (1) | IL-17 (1) | IL-1β (1) |
| IL-6 (2) | IL-MAE (2) | Illicit Drugs (1) |
| Illiterate (1) | Iloperidone (1) | image analysis (1) |
| imidazole (1) | Immediate release layer and Bioavailability (1) | Immune response (1) |
| Immune suppression (1) | Immune system (1) | immunocytochemistry (1) |
| Immunoinformatics (1) | Immunological response (1) | Immunomodulatory (2) |
| Immunomodulatory effect (1) | Immunomodulatory model (1) | Impact (1) |
| Impacted (1) | Improving (1) | Impurity (1) |
| Impurity related substances (1) | In silico (2) | In silico docking (1) |
| in situ gelation (1) | in vitro (4) | In vitro kinetics (1) |
| In vitro penetration lotion (1) | In vitro penetration test (1) | In vitro Penetration Test. (1) |
| In vitro release (1) | In vitro–In vivo (1) | in vivo (1) |
| In vivo kinetics (1) | In-patien (1) | In-situ gel (1) |
| in-vitro dissolution study (1) | In-vitro skin permeation (1) | Inappropriateness (1) |
| Inclusion complex (1) | Inclusion Complexation (1) | inclusion complexes (2) |
| indexed cost (1) | India (11) | India. (2) |
| Indian context (1) | Indian publications (2) | Indian Traditional medicine (1) |
| India’s publications (1) | Indigenous (1) | Indion 234 (2) |
| Indion resin (1) | indomethacin (2) | Indonesia (3) |
| Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) | Industry (2) |
| Inequality (1) | infarct size (1) | Infection prevention (1) |
| infective endocarditis (1) | infertility (1) | Infit and outfit indices (1) |
| inflammation (4) | inflammatory bowel disease (2) | Inflammatory markers. (1) |
| Inflorescence (2) | Information need (1) | Information system (1) |
| Information Technology Officers (1) | Information tool (1) | Inhibitor MDM2 (1) |
| Inhibitory activity (1) | Injectable (1) | innovation ecosystems (1) |
| inorganic salts. (1) | Inquiry learning (1) | INR (1) |
| inß ammation (2) | inß ammatory bowel diseases (1) | Insilico anticancer screening (1) |
| insulin (6) | Insulin receptor (1) | Insulin regimen (1) |
| insulin resistance (1) | Insulin resistance. (1) | insulin use in primary care (1) |
| Insulinophobia (1) | Integrase inhibitor (1) | Integrated Courses (1) |
| integrated economic analysis (1) | Intellectual Property l (1) | Intellectual property rights (1) |
| intelligent tutoring (1) | Intensive care unit (1) | Intensive Care Unit (ICU) (1) |
| Intensive Monitoring (1) | interaction (2) | interferon (1) |
| interleukins (1) | International Collaboration (1) | International HIV dementia scale (IHDS) (1) |
| international organization (1) | international organizations (1) | international trade (1) |
| Internet (1) | Internet pharmacy (1) | Interocclusal device (1) |
| interpretation (1) | Interventional tool (1) | Interventions (1) |
| Intervertebral disc C4/5 and C5/6 (1) | Interview (1) | Intoxications (1) |
| Intracanal medicament (1) | Intranasal delivery (1) | Intranasal Microemulsion (1) |
| intraocular presuure (1) | Intrauterine Pregnancy (1) | Intravenous (1) |
| Intravenous immunoglobulin (1) | Intrinsic and Extrinsic factors (1) | Invasive fungal infection (1) |
| inventory index (1) | inventory management (3) | Investigation (1) |
| investigators (1) | Invited Article (2) | Ion Gelation Method (1) |
| ion pair complex (1) | Ionic gelation (1) | Ionic liquid (3) |
| Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) | Ionizing radiation (1) |
| ionotropic gelation (1) | iontophoresis (2) | Ipsilateral symptoms (1) |
| Iraq (1) | Iridoid glycoside (1) | iron chelation therapy (1) |
| Irrational (1) | Irrigation (1) | Irvingia gabonensis (1) |
| isatin (3) | ischemia (1) | ischemia-reperfusion injury (1) |
| Ischemic (1) | ischemic heart disease (1) | ISO (1) |
| Isolated aortic rings (1) | isoniazid (3) | isonicotinohydrazide (1) |
| Isoprinosine (2) | Isopropyl myristate (1) | isoproterenol (1) |
| isoxazoline (1) | itopride HCl (1) | IV Admixture (1) |
| Jan-Aushadi (1) | JNC 8 Guidelines. (1) | Journal (1) |
| Jurkat (1) | K+-ATPase β subunit (1) | K+ATP channel (1) |
| K-CAPS (1) | K562 (1) | Kaffir lime (1) |
| Kaifyat (1) | Kajjali (1) | Kakoli (1) |
| Kalanchoe Pinnata (1) | Kantakari (1) | KAP (3) |
| KAP Questionnaire (1) | KAP study (1) | Kappa Concordant value (1) |
| Kappa. (1) | Karachi (2) | Kathakakhadiradi kashyam (1) |
| Kati chakrasana (1) | Kawasaki disease (1) | Kernel powder (1) |
| Ketamine (1) | Ketoacidosis. (1) | Ketoprofen (1) |
| Ketorolac (1) | Ketorolac salt (1) | Key words: 5-FU (1) |
| Key words: COVID-19 (1) | Key words: Esomeprazole (1) | kidney (2) |
| Kidney stones (1) | Kidney Transplantation (1) | kinetic drug release (1) |
| Kinetic Modelling (1) | KMnO4 (1) | Kneading (1) |
| kneading method (1) | kneading technique (1) | knowledge (22) |
| Kojic acid (1) | Kumar’s score (1) | Kushta (1) |
| Kushta Gaodanti (1) | L-arginine (1) | L-Thyroxine (1) |
| L. acidophilus (1) | labeling (1) | Laboratory findings. (1) |
| Lacosamide (1) | Lactate dehydrogenase (1) | Lactobacilli (2) |
| Lactobacillus (1) | Lag period (1) | Lagenaria siceraria (1) |
| Lantana camara (1) | Lantana montevidensis (1) | Larvacidal (1) |
| Larvicidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) |
| LC-MS (1) | LC-MS/MS (1) | LC/MS/MS (1) |
| LC50 (1) | LCMS/MS (2) | LC–MS/MS (1) |
| LDL-C (1) | Lead monoxide (1) | Leaf (1) |
| Learning (1) | Learning process (1) | leaves (4) |
| Left renal artery stenosis (1) | Leftover medicines, (1) | Leg Length (1) |
| Leptin (1) | Letter to Editor (4) | Letter to the Editor (3) |
| Letters to the Editor (6) | Leucaena leucocephala (1) | Leucas lavandulaefolia (1) |
| Levocetirizine (2) | Levodopa (1) | Levofloxacin (1) |
| Lexicomp (1) | Lichen planus (1) | Licofelone (1) |
| Ligand-based drug design (1) | Light and dark model (1) | Lightening (1) |
| Limb Length (1) | Limbs (1) | lime fruit (1) |
| Linagliptin (1) | Lindernia ciliata (1) | Linezolid (1) |
| Linoleic acid (1) | lipid matrix (1) | lipid metabolism (2) |
| Lipid Microparticles (1) | lipid microspheres (1) | Lipid nanocrystals (1) |
| Lipid peroxidation (3) | Lipid peroxidation. (1) | lipid peroxides (1) |
| lipid profile (1) | Lipid profile membrane bound enzymes (1) | lipids (1) |
| Lipinski rule. (1) | lipoic acid (1) | liposome (1) |
| Lippia (1) | Liquid chromatography (1) | Litharge (1) |
| Lithium (1) | lithium toxicity (1) | Live-well™ (1) |
| liver function (2) | Liver necrosis (1) | Liver tonic (1) |
| Liver Transplantation (1) | Local drug delivery (1) | Lockdown (1) |
| locomotor activity (1) | Long term memory (1) | Low-density lipoprotein cholesterol (1) |
| Lozenges (1) | LRTIs (1) | Luffa echinata (1) |
| Lumbar Spinal Stenosis (1) | Luminesce (1) | Lung (1) |
| Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
| Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
| Lymphocyte (1) | Lymphoma (1) | Lysozyme (1) |
| M. tuberculosis H37Rv (1) | MABA method (1) | Maceration (1) |
| Macromicroscopy study (1) | Macrophage (1) | Macrophage cell line (1) |
| Mahkoside A (1) | Major Contributed Organizations (1) | Malaysia (5) |
| Malaysia. (1) | Malaysian. (1) | Male (1) |
| Male fertility (1) | Maleic Acid (1) | Malignant lesions (1) |
| Malignant transformation (1) | Malocclusion (2) | malondialdehyde (2) |
| Maltodextrin (2) | Mammary carcinoma (1) | Mandibular hypoplasia (1) |
| Mangiferin (1) | Mangosteen Peels (1) | manidipine dihydrochloride (1) |
| Mannich base (1) | Mannich Bases (1) | Marine fungi compounds (1) |
| Marketed Brands (1) | Mast cell (1) | Maternal Care. (1) |
| Mathematical modeling (1) | matrix (1) | Matrix Tablet (1) |
| matrix tablets (3) | Maxillofacial complications (1) | MCF-7 (1) |
| MD simulation (1) | MDA (2) | MDR-TB (2) |
| mean age (1) | Mechanism (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | Medical and non-medical (1) |
| medical costs (1) | Medical device (1) | Medical device recalls (1) |
| medical errors (1) | Medical informatics (1) | Medical Inpatients (1) |
| Medical practitioner (1) | Medical Representative (1) | Medical Respresntative (1) |
| Medical sales representative (1) | Medical students (2) | medication adherence (6) |
| medication adherence behaviour (1) | medication error (2) | Medication errors (2) |
| Medication non-adherence (1) | Medication reconciliation (1) | Medication regimen complexity (1) |
| Medication related problems. (1) | medication safety (2) | Medication taking (1) |
| Medication taking behaviour. (1) | Medication understanding (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medications (1) | Medicinal ornamental plants (1) | Medicinal plant (1) |
| Medicinal plants (4) | Medicine (2) | Medicine consumers (1) |
| Medicine disposal (1) | medicine-use practices (1) | Medicines storage (1) |
| Medicines wastage (1) | Mediterranean diet (1) | Megakaryocytes (1) |
| Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
| Meloxicam (1) | Memory (2) | Memory and learning. (1) |
| Men (1) | Men who have Sex with Men (1) | Men who have Sex with Men. (1) |
| Menaquinone-4 (1) | Menstrual cycle (1) | Mental Disorders (1) |
| Mental health (4) | Mental health challenges (1) | Mental health education (1) |
| Mental health services. (1) | Mentha arvensis (1) | Menthol oil (1) |
| mesalamine (1) | Metabolic ratio (1) | Metabolic syndrome (1) |
| Metabolism (1) | Metabolite profiling (2) | Metabomics (1) |
| metagenomic (1) | metformin (9) | metformin hydrochloride (1) |
| Methanol (1) | methanolic extract (1) | methocel (2) |
| method development (5) | method development. (1) | Method optimization (1) |
| method validation (5) | Method validation Valsartan (1) | Methotrexate (1) |
| methyl orange (1) | methyl-b cyclodextrin (1) | metoprolol tartarate (1) |
| MetS (1) | Mevalonate (1) | MHCs (1) |
| Mice. (1) | Micelle (1) | Micro emulsion (2) |
| Micro particles. (1) | Micro-emulsion (1) | microbial contamination (1) |
| Microbiological (1) | Microbroth dilution (1) | Microcapsules (1) |
| microcrystalline cellulose (5) | microdilution (1) | Microdosing (1) |
| Microemulsion (1) | Microencapsules (1) | Microenvironment. (1) |
| microneedles (1) | Micronucleus assay (1) | microparticles (1) |
| MicroRNA (1) | microsphere (1) | Microsphere Phytosome (1) |
| microspheres (6) | microtriches (1) | Microwave assisted extraction (1) |
| Microwave-Assisted Extraction (2) | miglitol (1) | Migraine (3) |
| migraine management, (1) | Migrant labor (1) | Mild neurocognitive disorder (1) |
| Milk (1) | Milnacipran (1) | Mimosa pudica (1) |
| Mineral trioxide aggregate (1) | minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) |
| mismatches (1) | mitochondria (1) | Mix mode (1) |
| MLR (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modafinil (1) |
| Modeling (1) | modern medicine (1) | modified melt dispersion technique (1) |
| Modified Starches (1) | MODY (1) | Mol inspiration (1) |
| Molar Incisor (1) | Molecular characterization (1) | Molecular docking (10) |
| molecular docking and anti cancer activity. (1) | Molecular Docking. (1) | Molecular Dynamic (1) |
| Molecular dynamics (3) | Molecular Dynamics Simulations (1) | Molecular Imprinted Polymer (1) |
| Molecular mimicry (1) | Molegro Virtual Docker 6.0 (1) | Molinspiration. (1) |
| Momordica charantia (1) | Momordicin II Natural Products (1) | monoamine oxidase B (1) |
| Monocots (1) | Monophyletic (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | Mood stabilizers (1) |
| moraceae (1) | Morbidity (1) | Morin and validation (1) |
| Moringa (1) | Moringa oleifera (3) | Moringa oleifera. (1) |
| Morisky medication adherence questionnaire (1) | Morocco (3) | Mortality (4) |
| Morus alba (2) | Mosquito repellent (1) | Mouth Dissolving Tablets (1) |
| mouth-dissolving film, (1) | Mpharm (1) | MPO activity (1) |
| MPTP (1) | MRI Contrast agents (1) | MTT Assay (2) |
| MTT assay. (1) | MTT method (1) | MUC2 (1) |
| MUC6 (1) | Mucoadhesive (1) | Mucoadhesive agent (1) |
| mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) |
| mucodhesive (1) | Mucormycosis (2) | Mulberry (1) |
| multi granules (1) | Multi Organ Failure (1) | Multidrug Resistant (1) |
| multidrug resistant pathogens (1) | Multidrug-resistant bacteria (1) | Multikinase Inhibitor (1) |
| multiparticulates (1) | multiparticulates dosage form (1) | Multiple myeloma (1) |
| Multiple Organ Dysfunction Syndromes (MODS) (1) | Multiple Organ Failure (1) | multiple regression (1) |
| multiple regression analysis (1) | Multisystem inflammatory syndrome-children (1) | Multitargeted drug (1) |
| Murdarsang (1) | Murraya koenigii L.Sprengel S.mutans (1) | Muscle tmd (1) |
| Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (2) | Mycophenolic acid (1) |
| Myelin pallor (1) | Myeloperoxidase (1) | myocardial infarction (2) |
| Myomectomy. (1) | Myrica esculenta (1) | Myristicin (1) |
| Myrobalan (1) | N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) |
| Na+/K+-Atpase (1) | NABP (1) | NACO. (1) |
| Nadi shuddhi pranayama (1) | Naftopidil (1) | Naltrexone (1) |
| nano size (1) | Nanocarriers (1) | Nanocellulose (1) |
| Nanocrystals (1) | Nanoemulsion (1) | Nanofibers (1) |
| Nanoformulation (2) | nanoformulations (1) | Nanonization. (1) |
| Nanopacticle (1) | Nanoparticle (3) | Nanoparticles (12) |
| Nanosuspension (1) | Nanosuspension tablets (1) | Nanosuspensions (1) |
| Naphthoquinone derivative (1) | NAPLEX (1) | naproxen (1) |
| Naranjo (1) | Naranjo algorithm (2) | Naranjo algorithm. (1) |
| Naranjo Causality Assessment (1) | Naranjo probability (1) | Naranjo Probability Scale (1) |
| Naranjo’s ADR probability scale (1) | Naranjo’s algorithm (1) | Narikel Lavan (1) |
| Narrow therapeutic index drugs (1) | Nasal delivery (1) | Nasal gel (1) |
| Nateglinide (1) | National Fomulary (1) | National Formulary (2) |
| National Health and Morbidity Surveys (1) | National policy (1) | National Policy of Pharmaceutical Assistance (1) |
| National Public Health Programs (1) | Natural (1) | natural compounds (3) |
| Natural deep eutectic solvent (1) | Natural Polymers (1) | natural products (5) |
| NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) | nebivolol hydrochloride (1) |
| Necrosis. (1) | need assessment (1) | Neoplasm (1) |
| Nepal (2) | Nephropathy (1) | Nephroprotective (4) |
| Nephrotic syndrome (1) | Nephrotoxicity (1) | Nerium indicum (1) |
| Network pharmacology (1) | Neurodegenerative diseases (1) | Neuronal development (1) |
| neuropathy (1) | Neuroprotection (1) | Neuroprotective (1) |
| Neurosurgical (1) | Neurotoxicity (1) | neutropenia (1) |
| Neutrophil (1) | nevirapine (1) | new molecule (1) |
| Newborns (1) | Nicorandil (1) | Nicotine (1) |
| Nicotine dependence (1) | Nifedipine. (1) | Nigeria. (1) |
| nigrostriatal pathway (1) | Nil (17) | Nill (19) |
| Nimesulide (1) | niosome (1) | Niosomes (1) |
| Nirmatrelvir (1) | Nitric acid (1) | Nitric oxide (5) |
| Nitrogen starvation (1) | Nitroglycerin (1) | NK cell (1) |
| NMDA (1) | NMDA receptors (1) | Noccik Kudinir (1) |
| Nodular skin lesions (1) | Non-adherence (1) | Non-linear (1) |
| Non-prescription medications (1) | non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) |
| Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) | nonamers. (1) |
| noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
| Nonomuraea longicatena (1) | nootropic (1) | Norfloxacin (1) |
| Normoglycemic rats (1) | northeast India (1) | Nortriptyline HCl UV detection. (1) |
| NOS (1) | Nose to brain delivery (1) | Nosocomial infections (1) |
| Nothopanax scutellarium (1) | Novel delivery (1) | Novel drug delivery system (1) |
| Novel Pyrimidines (1) | NPCB (1) | NSAIDs (3) |
| Nuclear medicine (1) | nuclear pharmacy (1) | Nucleo CMP (1) |
| Nude mice (1) | Nurses (1) | Nutmeg oil (1) |
| Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
| Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (5) |
| Occupational health (1) | Ocimum gratissimum (1) | Odontopediatric (1) |
| Odorant binding Protein (1) | OECD (1) | Off-label (1) |
| offending drugs (1) | Ofloxacin (1) | Okra Mucilage (1) |
| Older people. (1) | Olmesartan (1) | olmesartan medoxomil (1) |
| Omega-6 fatty acid (1) | Omeprazole. (1) | Omics (1) |
| Oncology. (1) | Oncopharmacists (1) | ondansetron (3) |
| ondansetron hydrochloride (1) | One health approach. (1) | Online health screening (1) |
| Online pharmacies (1) | OPD – Outpatient Department. (1) | open field (1) |
| Open field task (1) | Open field Tinospora cordifolia Linn (1) | Ophthalmic (1) |
| ophthalmic delivery (1) | ophthalmic inserts (1) | Ophthalmology (1) |
| Opinion (1) | Opportunities (1) | Opportunity (1) |
| Opsoclonus myoclonus syndrome (OMS) (1) | Optimal stress (1) | optimization (9) |
| Oral bacteria (1) | Oral cancer (3) | Oral cancer. (1) |
| Oral diagnosis (1) | Oral disease (1) | Oral diseases (1) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| Oral Health (1) | oral hygiene (1) | Oral hypoglycemic agents (1) |
| Oral hypoglycemic drugs (1) | oral insulin (1) | Oral manifestations (1) |
| Oral Medicine (1) | Oral potentially malignant disorders (1) | Oral Rehabilitation (1) |
| Oral route (1) | Oral Surgery (2) | Orally disintegrating tablets (1) |
| Organ Toxicities (1) | organic acids (1) | Organizational Culture (1) |
| organogel (1) | Organophosphate (1) | ORIF (1) |
| Origanum vulgare (1) | Original Article (3) | Originator. (1) |
| Orlistat (2) | orodispersible tablet (1) | orodispersible tablets (2) |
| Oscillopsia (1) | Osmotic pump (1) | Osseointegration (2) |
| Osteoarthritis (3) | Osteoblast (3) | Osteoclast (2) |
| Osteonecrosis (1) | Osteoporosis (1) | OTC switch (1) |
| Otomycosis (2) | Outcome therapy (1) | Outdoor patients (1) |
| Outpatient Pharmacy (1) | Outpatient Psychiatry (1) | Outpatients (1) |
| Outside Pharmacy (1) | ovalbumin (1) | Ovarian (1) |
| Ovarian Cyst (1) | Over dosage (1) | Over the counter (1) |
| Over-the-counter (1) | Overweight (1) | OVX (1) |
| Oxalic acid (1) | oxazepinone (1) | oxcarbazepine (1) |
| Oxidation (1) | oxidative damage (1) | oxidative stress (6) |
| Oxidative Stress. (1) | Oxyresveratrol (2) | oxytetracycline (1) |
| P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
| P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p21SNFT (1) |
| p53 tumor suppressor gene (1) | Package insert (1) | Paediatric (2) |
| Paediatrics (1) | Pain (2) | Pain scale (1) |
| Pain thresholds (1) | Pain. (1) | Painkiller (1) |
| pair wise procedures (1) | Pakistan (3) | Pakistan. (4) |
| Palbociclib (1) | Paliperidone palmitate (1) | Pancreatitis. (1) |
| Pandemic (1) | Pantoprazole (1) | papain (3) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (6) | Paracetamol. (3) | Paraneoplastic (1) |
| Paresis (1) | Parkinson’s disease (2) | Partial coverage occlusal plaques (1) |
| partial least square (1) | Particle Shape. (1) | particle size analysis (1) |
| PASS (1) | passive avoidance learning (1) | Patch (1) |
| patents (4) | Pathological response (1) | Patient (2) |
| Patient adherence. (1) | Patient Care (1) | patient counseling (2) |
| Patient counseling and Patient information leaflet (1) | Patient Counselling (1) | patient education (2) |
| Patient health questionnaire (PHQ) (1) | Patient information leaflet (1) | Patient initiated adverse drug reporting (1) |
| Patient Safety (3) | Patient satisfaction (2) | Patient Satisfaction Questionnaire (1) |
| Patient Survival (1) | Patient-Pharmacist Intercommunication (1) | patient-physician communication (1) |
| Patient-safety (1) | patients (4) | Patients. (1) |
| paw edema (1) | Paw edema. (1) | Paw volume (1) |
| PE 18:0/18:0-PEG 2000 (1) | Pectin (1) | pedagogy (1) |
| Pediatric (3) | Pediatric cancer (1) | Pediatric Dentistry (1) |
| Pediatrics (1) | Pediculosis (1) | Pegagan extract (1) |
| PEGylation (1) | Pemphigus vulgaris (1) | Penang (1) |
| penetration (3) | penetration enhancer (1) | penetration pressure (1) |
| penicillamine (1) | Penicillins (1) | Pentazocine (1) |
| pentylenetetrazole (1) | PEO (1) | Peperomia pellucida (L) Kunth (1) |
| Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) | Peppermint oil (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | Peptidoglycan (1) |
| percentage healing of wound area (1) | Percentage wound closure (1) | perception (11) |
| Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
| periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
| Periodontitis (1) | Peripheral Neuropathy (1) | Permanent (1) |
| Permeation (5) | Permeation enhancer (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) |
| Persistent ulcer (1) | Personal care products (2) | Persons and items reliability (1) |
| Petechiae (1) | pH dependent approach (1) | pH independence (1) |
| pH-sensitive (1) | Phagocytosis (1) | Phaleria marcocarpha (1) |
| Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) | pharma counseling (1) |
| pharmaceutical (1) | pharmaceutical advertisements (1) | Pharmaceutical care (2) |
| Pharmaceutical Care service (1) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
| Pharmaceutical Industry (1) | Pharmaceutical Marketing (1) | Pharmaceutical marketing. (1) |
| Pharmaceutical packaging (1) | Pharmaceutical Sciences (1) | Pharmaceutical Services (2) |
| Pharmaceutical-Care (1) | Pharmaceutical-industries (1) | Pharmaceutics (1) |
| Pharmacist (6) | Pharmacist intervention (1) | Pharmacist intervention. (1) |
| pharmacist role in public health (1) | Pharmacist. (1) | Pharmacists (2) |
| pharmacists India (1) | Pharmaco epidemiology (1) | Pharmacodynamic (4) |
| Pharmacodynamic activity (1) | pharmacodynamics (2) | Pharmacoepidemiology (1) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | Pharmacognostic (1) |
| pharmacognostic standardization (1) | pharmacognostical (1) | Pharmacognosy (1) |
| pharmacognosy study (1) | Pharmacokinetic (7) | Pharmacokinetic interactions. (1) |
| Pharmacokinetic software (1) | Pharmacokinetic study (1) | pharmacokinetics (10) |
| Pharmacokinetics. (2) | Pharmacological properties (1) | Pharmacophore (3) |
| Pharmacosomes (1) | Pharmacotherapy (2) | Pharmacovigilance (22) |
| Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
| Pharmacovigillance (1) | pharmacy (7) | pharmacy curriculum (2) |
| Pharmacy education (1) | Pharmacy education. (1) | Pharmacy Enforcement Division (1) |
| Pharmacy informatics (1) | Pharmacy intervention (1) | Pharmacy practice (2) |
| Pharmacy services (1) | Pharmacy store (1) | Pharmacy student (1) |
| Pharmacy students (3) | PharmD (1) | Phase diagrams (1) |
| Phase I studies (1) | Phase rule (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
| phenolic compounds (2) | Phenolic content (1) | phenolics (1) |
| phenols (1) | Phenothiazine (1) | Phenytoin (7) |
| Phenytoin cold cream (1) | Phenytoin Toxicity (1) | Pheretima and Anthelmintic (1) |
| Pheritima posthuma (1) | Phleboliths (1) | Phoenix dactylifera (1) |
| Phospholipid E80 (1) | Phosphorylase kinase (1) | Photocuring-Based Bioprinting (1) |
| Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
| Phyllanthus reticulatus (1) | Phylogenetic tree (1) | Phylogeny (1) |
| Physical activity (1) | Physical fitness (1) | Physical stability (1) |
| Physichochemical Characterization (1) | Physicians (5) | Physicochemical (1) |
| physicochemical evaluation (1) | physicochemical properties (1) | Physicochemical Tests (1) |
| Physicochemical. (1) | physiochemical descriptor (1) | Physiological role (1) |
| Phytochemical (2) | phytochemical prospection (1) | Phytochemical screening (2) |
| Phytochemicals (1) | Phytoconstituents (1) | Phytomolecule (1) |
| Phytopharmaceutical drug (1) | Phytosome (1) | picrotoxin (1) |
| pictograms (1) | Pilgrims (1) | PIM (1) |
| Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
| Piperidino thiophene (1) | Piperine (2) | Piroxicam (2) |
| Pits and Fissures (1) | Pixel intensity. (1) | Placements (1) |
| Plackett-Burman (1) | Plackett-Burman design (1) | plant extracts (1) |
| plasma (3) | Plasma concentration (1) | plasma concentrations (1) |
| Plasma creatinine (1) | Plasma glucose (1) | Plasma insulin (1) |
| Plasma urea (1) | plasma-brain correlation (1) | Plasma. (1) |
| Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) | Platelet (1) |
| Platelet aggregation. (1) | Platelet concentrates (1) | Platelet rich fibrin membrane. (1) |
| Pleiotropic effects (1) | PLGA (1) | PLS (1) |
| PLSR (1) | Pluronic (1) | Pluronic F 127 (1) |
| PM6 (1) | PM7 (1) | Pneumonia (2) |
| POGIL (1) | Point-measure correlation coefficients (1) | Poison (2) |
| Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
| Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
| Poly herbal (1) | poly(ε-caprolactone) (1) | Poly-herbal (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymer (1) | Polymeric nanoparticles (3) |
| Polymorphism (1) | polypharmacy (8) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
| Pomalidomide (1) | PON1 mRNA (1) | porosity (1) |
| Port-A Catheter. (1) | Portfolio (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Post marketing (1) | Post SARS-COV-2 infection (1) | Post-antibiotic era (1) |
| Posterior reversible encephalopathy syndrome (1) | Postpartum depression/Postnatal depression (1) | Potassium (1) |
| Potassium Channel (1) | Potassium chloride (1) | Potassium Nitrate (1) |
| Potential Drug-Drug Interaction (1) | Potentially malignant lesions (1) | POTS (1) |
| Powder (1) | PPAR agonists (1) | PPARγ agonists. (1) |
| PPBG (1) | pPharmacokinetics (1) | PPP model (1) |
| practice (5) | practices (1) | pravastatin (1) |
| Pre ADMET (1) | pre prandial (1) | Pre University students (1) |
| Pre-authorization (1) | Pre-Exposure Prophylaxis (1) | Pre-school (1) |
| Prebiotic (2) | Preceptors (1) | Precipitation (1) |
| precise (1) | Precision (1) | Predictors (3) |
| Pregabalin (1) | Pregnancy (5) | preliminary screening (1) |
| Premna esculenta (1) | Preparedness (1) | prescriber (1) |
| Prescribing (2) | Prescribing errors (2) | Prescribing indicators (1) |
| Prescribing pattern (3) | Prescribing pattern and Prescription Quality (1) | Prescribing pattern. (1) |
| Prescribing Trend (1) | Prescription (3) | Prescription audit (1) |
| Prescription error. (1) | prescription monitoring (1) | prescription only medicines (1) |
| Prescription pattern (3) | Prescription patterns (1) | Prescription refill (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (6) |
| Prevalence. (1) | Prevention (1) | Prevention. (1) |
| Price variation (1) | Primary dentition. (1) | Primary health care (2) |
| Primary Health Care. (1) | Primary tooth (1) | Principal component analysis (1) |
| principal component regression (1) | Pristane (1) | Private Medical College (1) |
| Private sector (1) | PRO (1) | Probable (1) |
| Probiotic (1) | Probiotics (2) | Problem-based learning (1) |
| process capability (1) | Process parameters. (1) | Product Surveillance (1) |
| Products with Antimicrobial Action. (1) | progesterone (1) | Proniosomal gel (1) |
| Property Intellectual (1) | Prophylaxis (2) | propolis (5) |
| Proportional reporting ratio (1) | propranol hydrochloride (1) | Propranolol hydrochloride (1) |
| Prospection (1) | Prospective (1) | Prospective Study (2) |
| prostaglandins (1) | Prosthesis Coloring (1) | Proteasome activity (1) |
| protein proÞ le (1) | proteolytic enzymes (1) | Proton adduct (1) |
| Proton Pump Inhibitor (2) | Proton pump inhibitors (1) | Proton-pump Inhibitors (1) |
| Protransfersome (1) | Prteomics (1) | Pseudo ternary phase diagrams (1) |
| Pseudomonas aeruginosa (1) | Psidium Guajava (1) | Psychiatric distress (1) |
| Psychiatric illness (1) | Psychiatric patients (1) | Psychiatric treatment (1) |
| Psychological factors (1) | Psychological mindedness (1) | Psychomotor (1) |
| Psychosis (2) | Psychosis. (1) | Psychotropic drugs (1) |
| Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
| Public behavior (1) | Public health (1) | Public health hospital (1) |
| Public hospital (2) | Public Service (1) | Publication (1) |
| Publications (7) | Pulmonary Fibrosis (1) | pulmonary hypertension (1) |
| Pulmonary toxicity (1) | Pulpectomy (1) | Pulse wave velocity (1) |
| Punica granatum (2) | Pyrazinamide (1) | pyrazine (1) |
| pyrazoline (1) | pyrazolines (2) | Pyrimidine (1) |
| Q1F (1) | QOL (1) | QRS-T angle (1) |
| QSAR (3) | qualitative (1) | Qualitative analysis (1) |
| Qualitative research (1) | qualitative study (1) | Quality (2) |
| Quality Assessment (1) | quality assurance (1) | Quality by design (QbD) (1) |
| Quality by design Ritonavir (1) | Quality Control (1) | Quality Indicators (1) |
| Quality of Health Care (1) | quality of internet information (1) | quality of life (10) |
| Quantification (1) | quantitative structure-activity relationship (1) | Quercetin (2) |
| Questionnaire (2) | Questionnaire. (1) | quinazolin-4(3H)one (1) |
| quinazolinone (1) | Quinazolinone. (1) | quinoline derivatives (1) |
| R2 values (1) | Rabbit plasma (1) | Rabbits. (1) |
| radical scavenger (1) | Radical scavengers (1) | radicals (1) |
| Radiculopathy (1) | Radio-mitigation (1) | Radiology Unit (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raltegravir potassium (1) |
| Raman spectroscopy (2) | ramipril (2) | ranitidine (1) |
| Ranitidine hydrochloride (2) | Ranitidine’. (1) | ranolazine (1) |
| Ransmission electron microscopy (1) | Rapid antigen test (1) | Rapid disintegration (1) |
| Rasagiline mesylate (1) | Rat (1) | ratio test procedures (1) |
| Rational pharmacotherapy. (1) | Rational prescribing (1) | Rational Use (2) |
| Rational use of Medication (1) | Rational use of medicine (1) | rational use of medicines (1) |
| rats (1) | Rattus novergicus (1) | Re-emerging viral infections (1) |
| re-precipitation (1) | Reactants (1) | Recent trends (1) |
| recognized standards (1) | recovery studies (1) | Recurrent oral ulcer (1) |
| Red ginger (1) | Reduction (1) | Reflective pedagogy paradigm (1) |
| Reflux diseases (1) | reforms (1) | Regeneration (1) |
| RegiSCAR score. (1) | Regression analysis (2) | Regressions statistics (1) |
| Regulation (1) | Regulations (1) | regulatory (2) |
| Regulatory affairs (1) | regulatory system (1) | Rehospitalisation (1) |
| Related substance (1) | Relative performance (1) | release kinetics (3) |
| Release studies. (1) | relese kinetics (1) | Removable denture (1) |
| Renoprotection (1) | Renoprotective (1) | Renovascular hypertension (1) |
| repaglinide (2) | reperfusion (1) | Repurposing (1) |
| research (1) | Research impact (2) | Research output (1) |
| Research Skills. (1) | reserpine (1) | Resident doctors (1) |
| Resistance (6) | Resistance. (1) | Resistant starch (1) |
| Resource poor setting (1) | Respiratory failure (1) | Respiratory tract (1) |
| Respiratory troubles (1) | Response Surface Methodology (3) | Response surface methodology. (1) |
| Response to antiretroviral therapy (1) | Resveratrol (2) | retail pharmacy (1) |
| Retention. (1) | Retinopathy (1) | retrospective cohort (1) |
| Retrospective study (4) | reversed-phase chromatography (1) | Review (1) |
| Rhabdomyolysis (1) | Rhaphidophora pinnata (1) | Rheumatology (1) |
| rhizomes (1) | Riboflavin (1) | Rice Bran Oil (1) |
| Rifampicin (2) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | Risk (1) | Risk Estimation Matrix (1) |
| Risk factor. (1) | Risk factors (6) | Risk Factors. (1) |
| Risk Groups (1) | Risk Management. (1) | Risk rating (1) |
| Risk-factors (1) | Rituximab (1) | rivastigmine (1) |
| RNA interference (1) | RNAi (1) | RNAi technology (1) |
| RNTCP (2) | ROB (1) | Rodenticides (1) |
| root (1) | Root canal filling materials (1) | Root canal infection (1) |
| Roots extract (2) | Ropinirole (1) | Roscoea purpurea (1) |
| rosuvastatin (2) | rosuvastatin calcium (1) | Rota rod test (1) |
| Royal Malaysian Custom Officer (1) | RP-HPLC (10) | RP-HPLC method (1) |
| RP-TLC/Densitometry (1) | RP-UFLC method (1) | RT-qPCR (1) |
| Rubus fraxinifolius (1) | Rubus rosifolius (1) | rupatadine (1) |
| rutin (1) | ß avonoids (2) | S. mutans (1) |
| S.salivarius (1) | S.sanguis (1) | Saccharin (1) |
| Safe handling guidelines (1) | Safety (2) | Safoof razyanaj (1) |
| Safoof-e- Binai (1) | Sage (1) | Saliva (2) |
| Sambung nyawa (1) | Sangunine. (1) | Saponin (2) |
| saponins (1) | Sappan wood (1) | Saraschandra (1) |
| SARS-CoV-2 (5) | Satisfaction (2) | Saudi Arabia (10) |
| Saudi Arabia. (2) | Saudi National Pharmacovigilance Centre (Saudi NPC) (2) | Saussurea (1) |
| Saussurea lappa (1) | SBVS (1) | Scale (1) |
| Scale for the assessment and rating of ataxia. (1) | scanning electron microscopy (3) | Schizophrenia (3) |
| Scientific Advertisements (1) | Scientometrics (13) | Scientometrics. (8) |
| Scientometrics1. (1) | sclerotherapy (1) | Scopolamine (1) |
| Scores. (1) | Scorpions (1) | Se- DeM ODT Expert system (1) |
| Second-line agents (1) | Secondary Level (2) | Sedation (1) |
| Sedation in pediatric patients (1) | Sedation scale (1) | seizure outcome (1) |
| Seizures (1) | seizures. (1) | Selected area electron diffraction (1) |
| Self efficacy. (1) | Self medication (1) | Self-directed learning (1) |
| self-emulsifying drug delivery system (1) | Self-Harm (1) | self-medication (7) |
| Self-Nano Emulsifying Drug Delivery System (SNEDDS) (1) | self-nanoemulsification (1) | Selfmedication (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
| Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
| Serum. (1) | sesame oil (1) | Severe acute respiratory syndrome coronavirus 2 (1) |
| Severe acute respiratory system coronavirus 2 (1) | severe febrile neutropenia (1) | Severe Neck Pain (1) |
| Severe sepsis (1) | Severity (2) | Sexual dysfunction in diabetes (1) |
| Sexuality (1) | SF-36 (1) | SG-alcohol. (1) |
| SG-Chloro (1) | SGLT-2 Inhibitor (1) | SGLT2 Inhibition (1) |
| Shark liver oil and Wound healing activity (1) | Shodhana (1) | Short Communication (3) |
| short-term memory (1) | Sida rhombifolia (1) | Sida rhomboidea.Roxb (1) |
| Side effect (1) | Side effects (1) | signal detection (1) |
| Signal detection. (1) | Signs and Symptoms (1) | Signs and Symtoms (1) |
| Silver nanoparticles (1) | silymarin (2) | Silymarin. (1) |
| Similarity factor (1) | similarity factor (f2) (2) | simplex lattice (1) |
| Simplex Lattice Design (2) | Simultaneous Delivery (1) | simultaneous determination (2) |
| simultaneous extraction (1) | simvastatin (1) | simvastatin. (1) |
| Single dual anticoagulant therapy (1) | Single nucleotide polymorphism (1) | Single-dual-triple antiplatelet therapy (1) |
| sintering (1) | siRNA (1) | siRNA. (2) |
| SIRT1 (1) | Sirtuin (1) | Sitagliptin (1) |
| Sitagliptin phosphate (1) | six sigma (1) | SJS (1) |
| Skin diseases (1) | Skin drug test (1) | Skin irritation (1) |
| Skin protection (1) | Skin whitening (1) | SLAM markers (1) |
| Sleep disorders (1) | SLS (1) | Smix (1) |
| Smix. (1) | Smoking (1) | smoking cessation. (1) |
| Smoking. (1) | smooth muscle cells (1) | Snake bite (1) |
| SNEDDS (2) | sobatum (1) | Social Media (1) |
| Social network analysis (1) | Social sexual. (1) | Sociodemographic factors (1) |
| Socioeconomic status (1) | SOD (1) | Sodium (1) |
| sodium alginate (1) | sodium alginate. (2) | sodium carboxy methyl cellulose (1) |
| sodium starch glycolate (3) | Sodium starch glycolate (SSG) (1) | Sodium Valproate (1) |
| Sofosbuvir (1) | Solanum giganteum (1) | Solanum nigrum (1) |
| Solanum surattense (1) | Solanum trilobatum (1) | Solanum viarum (1) |
| Solanum xanthocarpum, (1) | Solasodine (1) | solid dispersion (5) |
| solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) |
| solubility (8) | Solubility enhancement (1) | Solubility. (1) |
| solvent casting (1) | solvent evaporation (4) | Solvent evaporation. (1) |
| sonication time (1) | sonophoresis (1) | Sorafenib (1) |
| Sources (1) | South Asia (1) | Spacedrepetition. (1) |
| spasmolytic (1) | speciÞ city (1) | Spectrometric (1) |
| spectrophotometry (2) | sperm count (2) | SPF (1) |
| Spiro compounds (1) | Spleen colony assay (1) | Spondylosis (1) |
| Sponge implantation (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | Sri Lanka (2) | ST segment elevation (1) |
| stability (4) | stability indicating (1) | stability indicating and validation. (1) |
| Stability indicating assay (1) | Stability indicating assay method (1) | stability indicating method of artemether (1) |
| stability indicating. (1) | Stability of the physical properties (1) | Stability test (1) |
| stability. (1) | stain removal (1) | stakeholders (1) |
| Standardization (7) | Standardized Zscore (1) | Staphylococcus aureus (1) |
| Staphylococcus sciuri (1) | Starlac (1) | Statin pathway (1) |
| Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
| Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
| Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
| Steroidal alkaloid (1) | Steudnera colocasiifolia (1) | Stevens Johnson Syndrome (1) |
| Stevens-Johnson syndrome (1) | Stilbene (1) | Stimulantia (1) |
| Stimuli (1) | Stomatitis under prosthesis (1) | Strabismus surgery (1) |
| Streptococci (1) | Streptococcus mutans (4) | Streptokinase (1) |
| Streptomonospora arabica (1) | Streptomyces (1) | Streptozotocin (2) |
| Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) | Streptozotocin. (1) |
| stress (3) | Stress degradation (1) | stress studies (2) |
| Stroke (1) | stroke and cardiac pacemaker. (1) | Stroke prevention (1) |
| structural descriptor (1) | Structured Communication. (1) | Stryphnodendron rotundifolium (1) |
| students (4) | Students. (1) | students’ residence (1) |
| Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) | Subarachnoid hemorrhage (1) |
| Subcutaneous fat (1) | sublingual films (1) | substituted acetophenones (1) |
| Succinic acid (1) | sucrase (1) | Sudan (1) |
| Sulfated polysaccharides (1) | Sulfonylurea (2) | Sulfonylureas (1) |
| Sulphorhodamine-B (1) | Sun (1) | sun protection factor (2) |
| Sunlight (1) | Sunscreens. (1) | Super disintegrants (1) |
| superdisintegrants (2) | Superdisintergrants (1) | Superoxide Dismutase. (1) |
| superoxidedismutase (1) | superporous hydrogel composite (1) | Supply Chain Management (1) |
| support staff. (1) | Supportive care (1) | Surface properties (1) |
| surfactant (1) | surfactants (2) | Surgery (2) |
| Surgical cutters (1) | surgical prophylaxis. (1) | Surgical. (1) |
| Survey questionnaire (1) | survey. (1) | Survival rate (1) |
| sustained release (3) | sustained release pellets (1) | sustained release. (1) |
| Susutained release layer (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (2) |
| swelling studies (1) | SWOT (1) | Symptom (1) |
| Symptoms (1) | Symptoms domain (1) | Synchronous spectrofluorimetry. (1) |
| Synergism. (1) | Synthesis (4) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) |
| Systematic review (2) | Systematic Review. (1) | Systemic Inflammatory response (1) |
| Systemic steroids. (1) | Systems biotechnology (1) | Systolic dysfunction. (1) |
| T cell epitope (1) | T lymphocytes (1) | T regs (1) |
| T2DM (1) | Tab. Pardopa (1) | Tablet Compression (1) |
| Tablet splitting (1) | Tacrolimus (2) | Tacrolimus Once Daily (1) |
| Tacrolimus Twice Daily. (1) | Tactile stimulation (1) | tail suspension test (1) |
| Takayasu arteritis. (1) | Tamarindus indica (1) | Tamilians (1) |
| Tamoxifen (1) | Tampering (1) | Target delivery (1) |
| Targeted drug delivery system (1) | taste masking (2) | tasteless complex (1) |
| taxane (1) | Taxanes (1) | Taxus baccata (1) |
| Teaching Hospital (1) | Technology (1) | technology-enhanced learning (1) |
| Tecoma stans (1) | tegument (1) | telmisartan (1) |
| Temporomandibular Joint (1) | Temporomandibular Joint Disoders (1) | TEN (1) |
| Tenatoprazole sodium (1) | Tengger (1) | Tenofovir disoproxil fumarate (1) |
| Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Tephrosia villosa (1) | Terminala bellerica (1) |
| Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) |
| terpenoids (1) | Tertiary Care (1) | Tertiary care hospital (3) |
| testicular damage (1) | testosterone (3) | Tetrapreniltoluquinone (1) |
| thalassemia major (1) | therapeutic angiogenesis (1) | therapeutic dose (1) |
| therapeutic drug monitoring (2) | therapeutic effectiveness (1) | Therapeutic Policies (1) |
| Thermoreversible gel (1) | Thiazolidinone (1) | Third Molar (1) |
| Thixogel (1) | Thixotropic (1) | THP-1 (2) |
| Three component system (1) | thrombocytopenia (1) | Thrombolysed subjects (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | Thrombophlebitis (1) |
| Thunderclap Headache (1) | Thyme oleoresin (1) | Thyroid diseases (1) |
| Thyrotoxicosis. (1) | Tigecycline (1) | time dependent approach (1) |
| Time lag (1) | Timed release (1) | Tissue distribution (1) |
| Tityus (1) | TLC (1) | TNF-α (1) |
| Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Tooth brushing (1) |
| Tooth Demineralization (1) | Toothbrushing (1) | Toothpaste (1) |
| Toothpaste. (1) | Topical delivery. (1) | Topical drug delivery system (1) |
| Topical herbs (1) | Topical treatment (1) | Topical. (1) |
| Total flavonoid (1) | Total flavonoid content (2) | Total phenolic (2) |
| Total phenolic content (1) | total polyphenolic content (1) | total quality management (1) |
| toxicity (5) | Toxicity. (2) | traditional medicine (2) |
| Training of Central sterile and supply department employees (1) | tramadol HCL (1) | Tramadol Hydrochloride (1) |
| Trans-cinnamic acid (1) | Trans-resveratrol (1) | Transcriptomics. (1) |
| transdermal (2) | transfer latency (1) | Transfersome (2) |
| Transfersomes (1) | Transfersomes. (1) | Translation (1) |
| Transmucosal (1) | Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) |
| Treatment (2) | Treatment adherence. (1) | Treatment outcomes (1) |
| Treatment success rate (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
| Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
| Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
| trinitrobenzene sulfonic acid (1) | Triphala (2) | triple distilled water (1) |
| Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
| Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
| Trypsin (1) | TSLP (1) | Tuberculosis (5) |
| Tuberculosis/HIV (1) | Tukhm-e-soya (1) | Tumor response (1) |
| Turkey (1) | Turmeric (1) | Turpentine oil (1) |
| Tween 80. (1) | Twisted (1) | Tylophora indica (1) |
| Tylophorinidine. (1) | Type 1 Diabetes (1) | type 2 diabetes (2) |
| Type 2 diabetes mellitus (1) | Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) |
| Type II Diabetes (1) | Type-1 Diabetes (1) | UACR (1) |
| UCPMP Guidelines (1) | Ultra violet detection (1) | Ultra-Fast Liquid Chromatography (UFLCDAD) (1) |
| Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) | Ultrasonography (1) |
| Unani (1) | Unani Medicine (1) | Unani medicine (5) |
| Uncemented (1) | Underutilization of insulin. (1) | Unethical practices. (1) |
| Unique device identification (1) | Universal health coverage (1) | Universities (1) |
| Unlicensed. (1) | Unnecessary use. (1) | Unused drugs (1) |
| Unused/Unwanted medicines (1) | UPLC-QToF-MS/MS (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
| Urban area (1) | urea (2) | Uremic toxins (1) |
| Urinary Hydrogen Peroxide (1) | Urinary Tract Infection (1) | Urinary tract infection (UTI) (1) |
| Urine Albumin to Creatinine Ratio (1) | Urine volume (1) | urolithiasis (1) |
| Urtica dioica L (1) | URTIs (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine fibroids (1) | Uterine Perforation. (1) |
| Utilization Pattern (1) | UV derivative spectrophotometry (1) | UV detection (2) |
| UV Spectrophotometric method (1) | UV spectrophotometry (2) | UV Spectroscopy (1) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | UV-Vis spectroscopy (1) |
| Vaccine (3) | Vaccine design (1) | vada (1) |
| vaginal gel (1) | Vaginitis. (1) | Vakrasana (1) |
| validation (21) | Validation. (1) | Valium (1) |
| Valproate (1) | valsartan (1) | Vanillin (1) |
| Vanillosmopsis arborea. (1) | vascular bundle (1) | vascular permeability (2) |
| vascular progenitors (1) | VED analysis (3) | VED analysis. (2) |
| VEGFR-2 (1) | Velpatasvir (1) | Venetoclax (1) |
| Venography and Hemangioma (1) | Venous malformations (VMs) (1) | verapamil (3) |
| Verapamil HCl (1) | Viability (1) | Vincristine. (1) |
| Vinegar (1) | VIPPS (Verified Internet Pharmacy Practice Sites) (1) | Virtual Screening (1) |
| Viscosity (1) | visible Spectrophotometry (1) | visible spectroscopy (1) |
| Visual analogue scale. (1) | Visual Analogues Score. (1) | Vitamin B12 (1) |
| Vitamin B6. (1) | Vitamin D (3) | Vitamin D deficiency (3) |
| Vitamin D. (1) | vitamin E (1) | vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) |
| Vitamin. (1) | Vitamins (1) | Vitex agnus Castus (1) |
| Vitex negundo (1) | Vitex negundo Linn (1) | Voltage–gated calcium channels (1) |
| Voriconazole (1) | Wabā (1) | warfarin (2) |
| Warning signs (1) | Water hyacinth (2) | web-based learning (1) |
| Weibull parameters (1) | West timor (1) | Western blot technique (1) |
| Wet gangrene (2) | wet granulation (2) | Wetting Property (1) |
| wetting time (1) | Wheat (1) | White/red patch (1) |
| WHO BREF QOL (1) | WHO core indicators (1) | WHO prescribing indicator (1) |
| WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) | Wilson disease (1) |
| Wistar rats. (1) | Withania somnifera. (1) | Withdrawal (1) |
| Women. (1) | Work protection (1) | Work Satisfaction (1) |
| World Anti-Doping Agency (1) | World Health Organization (1) | Worldwide (1) |
| Wound care (1) | Wound Healing (1) | Wound tissue healing (1) |
| Woundhealing. (1) | Wrightia tinctoria (1) | writhing (1) |
| X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
| xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
| Xenografts (1) | Xenografts. (1) | XRD (1) |
| Xylitol (2) | Ylang-ylang (1) | Yoga (1) |
| Young (1) | Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) |
| Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
| zidovudine (2) | Zika virus (1) | Zikavirus Infection (1) |
| zinc (1) | Zinc ion (1) | Zingiber officinale (1) |
| Zingiberaceae (1) | zopiclone (1) | [BMIM]PF6 (1) |
| Þ rst-order derivative spectroscopy (1) | Α-amylase (3) | α-glucosidase (2) |
| α-mangostin (1) | α1 adrenergic antagonist (1) | β amyloid protein (1) |
| β Amyloid1-42 (1) | β-carboline (1) | β-carotene production (1) |
| β-cyclodextrin (3) | γ-oryzanol (1) | γ-retroviral vector (1) |
| ε-amino groups (1) | | |
